Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?
Babazono
Akira
A
Institute of Health Science, Kyushu University, Kasuga City, Fukuoka, Japan. babazono@ihs.kyushu-u.ac.jp
Miyazaki
Motonobu
M
Une
Hiroshi
H
Yamamoto
Eiji
E
Tsuda
Toshihide
T
Mino
Yoshio
Y
Hillman
Alan L
AL
D000328:Adult; D000367:Age Factors; D000368:Aged; D000428:Alcohol Drinking; D000553:Ambulatory Care / Q000191:economics*; D000907:Antibodies, Bacterial / Q000097:blood*; D016208:Databases, Factual; D004381:Duodenal Ulcer / Q000191:economics* / Q000453:epidemiology / Q000382:microbiology; D005756:Gastritis / Q000191:economics* / Q000453:epidemiology / Q000382:microbiology; D017048:Health Care Costs; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D007348:Insurance, Health / Q000191:economics; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012907:Smoking; D013276:Stomach Ulcer / Q000191:economics* / Q000453:epidemiology / Q000382:microbiology
D000907:Antibodies, Bacterial